Exhibit 5.1
| | | | | | |
| | 30 ROCKEFELLER PLAZA NEW YORK, NEW YORK 10112-4498 TEL +1 212.408.2500 FAX +1 212.408.2501 BakerBotts.com | | AUSTIN BEIJING BRUSSELS DALLAS DUBAI HONG KONG HOUSTON | | LONDON MOSCOW NEW YORK PALO ALTO RIYADH SAN FRANCISCO WASHINGTON |
November 6, 2018
New York Community Bancorp, Inc.
615 Merrick Avenue
Westbury, New York 11590
Ladies and Gentlemen:
In connection with the issuance by New York Community Bancorp, Inc., a Delaware corporation (the “Company”), of $300,000,000 aggregate principal amount of the Company’s 5.90%Fixed-to-Floating Rate Subordinated Notes due 2028 (the “Notes”) pursuant to (i) the Registration Statement on FormS-3 (RegistrationNo. 333-210919) (the “Registration Statement”), which was filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”), and (ii) the base prospectus contained in the Registration Statement, as supplemented by the prospectus supplement of the Company relating to the sale of the Notes dated November 1, 2018 (the base prospectus as so supplemented, the “Prospectus”), as filed by the Company with the Commission pursuant to Rule 424(b) under the Act, certain legal matters with respect to the Securities are being passed upon for you by us. At your request, this opinion is being furnished to you for filing as Exhibit 5.1 to the Current Report of the Company on Form8-K to be filed with the Commission on or about the date hereof (the “Form8-K”).
The Notes are to be issued under an Indenture, to be dated as of November 6, 2018 (the “Base Indenture”), between the Company and Wilmington Trust, National Association, as Trustee, as supplemented by the First Supplemental Indenture, to be dated as of November 6, 2018 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), establishing the terms of the Notes.
In our capacity as your counsel in the connection referred to above, we have examined originals, or copies certified or otherwise identified, of (i) the Registration Statement and the Prospectus, (ii) forms of the Base Indenture and the Supplemental Indenture, (iii) the Underwriting Agreement, dated November 1, 2018 (the “Underwriting Agreement”), by and among the Company and the Underwriters named in Schedule I thereto (the “Underwriters”), relating to the issuance and sale of the Notes, (iv) the Company Order delivered pursuant to the Indenture and dated November 6, 2018, (v) the Amended and Restated Certificate of Incorporation of the Company, as amended through the date hereof, and the Amended and Restated Bylaws of the Company, (vi) corporate records of the Company and (vii) certificates of public officials and of representatives of the Company, statutes and other instruments and documents as a basis for the opinions hereinafter expressed.
In giving the opinions below, we have relied, to the extent we deemed proper, without independent investigation, upon (i) certificates, statements and other representations of officers and other representatives of the Company and of governmental and public officials with